Novartis Completes Spinoff of Alcon Eye Care Business
Novartis Completes Spinoff of Alcon Eye Care Business
GALWAY, IRELAND--April 24, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Swiss pharmaceutical major Novartis International AG (NYSE:NVS) (Basel, Switzerland) has completed the planned spinoff of its Alcon eye-care business.
Within this article: Details spinoff of Alcon business, Novartis shift to higher margin medicines, job cuts and proposed "blockbuster" medicines on the way
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company